ATC codes:
L01CA02
EMLc
Indication
Rhabdomyosarcoma primary site
ICD11 code:
2C25.Z
INN
Vincristine
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
1 mg in vial (vincristine sulfate) ;
5 mg in vial (vincristine sulfate) ;
1 mg per mL in vial (vincristine sulfate) ;
2 mg per 2 mL in vial (vincristine sulfate)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the addition of new strength formulations of vincristine IV injection (1mg/mL and 2 mg/2mL) to the EML and EMLc.